{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T23:42:11Z","timestamp":1769038931120,"version":"3.49.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MenAfriNet consortium"},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1084298"],"award-info":[{"award-number":["OPP1084298"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>After the re-emergence of serogroup C meningococcal meningitis (MM) in Nigeria and Niger, we aimed to re-evaluate the vaccination policy used to respond to outbreaks of MM in the African meningitis belt by investigating alternative strategies using a lower incidence threshold and information about neighboring districts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used data on suspected and laboratory-confirmed cases in Niger and Nigeria from 2013 to 2017. We calculated global and local Moran\u2019s I-statistics to identify spatial clustering of districts with high MM incidence. We used a Pinner model to estimate the impact of vaccination campaigns occurring between 2015 and 2017 and to evaluate the impact of 3 alternative district-level vaccination strategies, compared with that currently used.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found significant clustering of high incidence districts in every year, with local clusters around Tambuwal, Nigeria in 2013 and 2014, Niamey, Niger in 2016, and in Sokoto and Zamfara States in Nigeria in 2017.<\/jats:p>\n                  <jats:p>We estimate that the vaccination campaigns implemented in 2015, 2016, and 2017 prevented 6% of MM cases. Using the current strategy but with high coverage (85%) and timely distribution (4 weeks), these campaigns could have prevented 10% of cases. This strategy required the fewest doses of vaccine to prevent a case. None of the alternative strategies we evaluated were more efficient, but they would have prevented the occurrence of more cases overall.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Although we observed significant spatial clustering in MM in Nigeria and Niger between 2013 and 2017, there is no strong evidence to support a change in methods for epidemic response in terms of lowering the intervention threshold or targeting neighboring districts for reactive vaccination.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiz343","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T15:26:29Z","timestamp":1567610789000},"page":"S244-S252","source":"Crossref","is-referenced-by-count":11,"title":["Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response"],"prefix":"10.1093","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-3627","authenticated-orcid":false,"given":"Laura V","family":"Cooper","sequence":"first","affiliation":[{"name":"University of Cambridge, Cambridge, United Kingdom, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Ronveaux","sequence":"additional","affiliation":[{"name":"Department of Pandemic and Epidemic Diseases, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katya","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Department of Pandemic and Epidemic Diseases, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement","family":"Lingani","sequence":"additional","affiliation":[{"name":"Inter-country Support Team for West Africa, World Health Organization, Ouagadougou, Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadade","family":"Goumbi","sequence":"additional","affiliation":[{"name":"Ministry of Public Health, Niamey, Niger"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikwe","family":"Ihekweazu","sequence":"additional","affiliation":[{"name":"Nigeria Center for Disease Control, Abuja, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pierre","family":"Preziosi","sequence":"additional","affiliation":[{"name":"Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Durupt","sequence":"additional","affiliation":[{"name":"Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline L","family":"Trotter","sequence":"additional","affiliation":[{"name":"University of Cambridge, Cambridge, United Kingdom, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"2019110101095145900_CIT0001","volume-title":"Control of epidemic meningococcal diseases: WHO practical guidelines","author":"World Health Organization","year":"1995"},{"key":"2019110101095145900_CIT0002","unstructured":"World Health Organization. Detecting meningococcal meningitis epidemics in highly endemic African countries. Wkly Epidemiol Rec2000 [cited 2016 Jan 23]; \n75:305. Available from: http:\/\/tf5lu9ym5n.scholar.serialssolutions.com\/?sid=google&aulast=World+Health+Organization&atitle=Detecting+meningococcal+meningitis+epidemics+in+highly-endemic+African+countries&title=Weekly+epidemiological+record&volume=75&issue=38&date=2000&spage=305&."},{"key":"2019110101095145900_CIT0003","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1016\/j.vaccine.2015.09.107","article-title":"Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac\u00ae","volume":"33","author":"Trotter","year":"2015","journal-title":"Vaccine"},{"key":"2019110101095145900_CIT0004","volume-title":"WHO Guideline on","author":"World Health Organization","year":"2014"},{"key":"2019110101095145900_CIT0005","article-title":"Analysing spatiotemporal clustering of meningococcal meningitis outbreaks in niger reveals opportunities for improved disease control","volume":"6:e1577","author":"Paireau","year":"2012","journal-title":"PLoS"},{"key":"2019110101095145900_CIT0006","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3201\/eid2108.141361","article-title":"Response strategies against meningitis epidemics after elimination of serogroup A meningococci, Niger","volume":"21","author":"Mainassara","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2019110101095145900_CIT0007","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/tmi.12815","article-title":"Evaluation of response strategies against epidemics due to Neisseria meningitidis C in Niger","volume":"22","author":"Ma\u00efnassara","year":"2017","journal-title":"Trop Med Int Heal"},{"key":"2019110101095145900_CIT0008","article-title":"Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in Northern Nigeria, 2013\u201314","volume":"6","author":"Funk","year":"2014","journal-title":"PLoS Curr"},{"key":"2019110101095145900_CIT0009","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1093\/cid\/civ597","article-title":"Meningococcal meningitis surveillance in the African Meningitis Belt, 2004\u20132013","volume":"61","author":"Lingani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019110101095145900_CIT0010","article-title":"World Health Organization. Meningococcal meningitis weekly reports. 2018. Available at: https:\/\/www.who.int\/emergencies\/diseases\/meningitis\/epidemiological\/en\/. Accessed 5 June 2018."},{"key":"2019110101095145900_CIT0011","article-title":"GeoNames. GeoNames. Available at: http:\/\/www.geonames.org\/. Accessed 5 June 2018."},{"key":"2019110101095145900_CIT0012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/biomet\/37.1-2.17","article-title":"Notes on continuous stochastic phenomena","volume":"37","author":"Moran","year":"1950","journal-title":"Biometrika"},{"key":"2019110101095145900_CIT0013","doi-asserted-by":"crossref","DOI":"10.1002\/0471662682","volume-title":"Applied Spatial Statistics for Public Health Data","author":"Waller","year":"2004"},{"key":"2019110101095145900_CIT0014","first-page":"93","article-title":"Local indicators of spatial association-LISA","volume-title":"Geogr Anal","author":"Anselin","year":"2010"},{"key":"2019110101095145900_CIT0015","unstructured":"Population Division - United Nations. World Population Prospects. 2015. Available at: http:\/\/esa.un.org\/unpd\/wpp\/Graphs\/. Accessed 11 November 2015."},{"key":"2019110101095145900_CIT0016","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz358","article-title":"Bacterial meningitis epidemiology in five countries in the meningitis belt of sub-Saharan Africa, 2015\u20132017","author":"Soeters","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101095145900_CIT0017","article-title":"Vaccine effectiveness of polysaccharide vaccines against clinical meningitis - Niamey, Niger, June 2015","volume":"8","author":"Rondy","year":"2016","journal-title":"PLoS Curr"},{"key":"2019110101095145900_CIT0018","volume-title":"Polysaccharide vaccines for preventing serogroup A meningococcal meningitis. Cochrane Database of Systematic Reviews","author":"Patel","year":"2005"},{"key":"2019110101095145900_CIT0019","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ije\/29.5.933","article-title":"Effectiveness of incidence thresholds for detection and control of meningococcal meningitis epidemics in northern Togo","volume":"29","author":"Kaninda","year":"2000","journal-title":"Int J Epidemiol"},{"key":"2019110101095145900_CIT0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/infdis\/166.2.359","article-title":"Epidemic meningococcal disease in Nairobi, Kenya, 1989","volume":"166","author":"Pinner","year":"1992","journal-title":"J Infect Dis"},{"key":"2019110101095145900_CIT0021","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"2019110101095145900_CIT0022","doi-asserted-by":"crossref","first-page":"S594","DOI":"10.1093\/cid\/civ508","article-title":"Modeling long-term vaccination strategies with MenAfriVac in the African meningitis belt","volume":"61","author":"Karachaliou","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019110101095145900_CIT0023","doi-asserted-by":"crossref","first-page":"e20162193","DOI":"10.1542\/peds.2016-2193","article-title":"Effectiveness and duration of protection of one dose of a meningococcal conjugate vaccine","volume":"139","author":"Cohn","year":"2017","journal-title":"Pediatrics"},{"key":"2019110101095145900_CIT0024","first-page":"97","article-title":"Epidemic meningitis control in countries of the African meningitis belt, 2017","volume":"93","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"2019110101095145900_CIT0025","first-page":"145","article-title":"Epidemic meningitis control in countries of the African meningitis belt, 2016","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"2019110101095145900_CIT0026","first-page":"209","article-title":"Meningitis control in countries of the African meningitis belt, 2015","volume":"91","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"2019110101095145900_CIT0027","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1016\/j.vaccine.2015.09.107","article-title":"Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac","volume":"33","author":"Trotter","year":"2015","journal-title":"Vaccine"},{"key":"2019110101095145900_CIT0028","doi-asserted-by":"crossref","first-page":"e0007077","DOI":"10.1371\/journal.pntd.0007077","article-title":"Analysis of a meningococcal meningitis outbreak in Niger \u2013 potential effectiveness of reactive prophylaxis","volume":"13","author":"Hitchings","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2019110101095145900_CIT0029","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz355","article-title":"Meningococcal meningitis outbreaks in the African meningitis belt after meningococcal serogroup A conjugate vaccine introduction, 2011\u20132017","author":"Fernandez","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101095145900_CIT0030","doi-asserted-by":"crossref","first-page":"14194","DOI":"10.1038\/s41598-018-32475-2","article-title":"Meningococcus serogroup C clonal complex ST-10217 outbreak in Zamfara State, Northern Nigeria","volume":"8","author":"Kwambana-Adams","year":"2018","journal-title":"Sci Rep"},{"key":"2019110101095145900_CIT0031"},{"key":"2019110101095145900_CIT0032","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/trstmh\/trw046","article-title":"Evaluation of Pastorex meningitis kit performance for the rapid identification of Neisseria meningitidis serogroup C in Nigeria","volume":"110","author":"Uadiale","year":"2016","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2019110101095145900_CIT0033","doi-asserted-by":"crossref","first-page":"e0212922","DOI":"10.1371\/journal.pone.0212922","article-title":"Culture and real-time polymerase chain reaction sensitivity in the diagnosis of invasive meningococcal disease: does culture miss less severe cases?","volume":"14","author":"Guiducci","year":"2019","journal-title":"PLoS One"},{"key":"2019110101095145900_CIT0034","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/0140-6736(92)92622-M","article-title":"Polymerase chain reaction for diagnosis of meningococcal meningitis","volume":"340","author":"Ni","year":"1992","journal-title":"Lancet"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/Supplement_4\/S244\/30339693\/jiz343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/Supplement_4\/S244\/30339693\/jiz343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T01:10:36Z","timestamp":1572570636000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/220\/Supplement_4\/S244\/5610777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":34,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2019,10,31]]},"published-print":{"date-parts":[[2019,10,31]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz343","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12,1]]},"published":{"date-parts":[[2019,10,31]]}}}